The effects of QSKL on the MAPK and RhoA pathways were studied in order to reveal the antifibrotic mechanisms of QSKL and offer an alternative approach for the clinical treatment of myocardial fibrosis. The gene discussed is RHOA; the disease is Myocardial fibrosis.